logo

LGN

Legence·NASDAQ
--
--(--)
--
--(--)
1.32 / 10
Underperform

Legence's fundamental score is low at 1.3/10, reflecting poor financial health. Key positives include Net income-Revenue and Revenue-Market Value, but significant weaknesses are evident in PB-ROE, Interest coverage ratio, and other equity metrics. Historical back-tests show limited upside potential, with most factor groups yielding modest returns and low confidence levels, underscoring the need for caution on the fundamental side.

Fundamental(1.32)SentimentTechnical

Analysis Checks(3/10)

Revenue-MV
Value0.64
Score2/3
Weight26.78%
1M Return16.02%
Annualized return on equity (%)
Value-12.22
Score0/3
Weight3.53%
1M Return3.06%
Net profit attributable to parent company shareholders / Net profit (%)
Value119.58
Score1/3
Weight0.90%
1M Return0.87%
Profit-MV
Value0.47
Score0/3
Weight6.29%
1M Return4.72%
Net income-Revenue
Value-5.44
Score2/3
Weight17.75%
1M Return11.34%
PB-ROE
Value0.16
Score1/3
Weight21.07%
1M Return12.05%
Cash-UP
Value0.76
Score2/3
Weight4.49%
1M Return3.97%
Interest coverage ratio (EBIT / Interest expense) (%)
Value0.90
Score0/3
Weight5.13%
1M Return4.02%
Asset-MV
Value-0.51
Score0/3
Weight10.52%
1M Return8.30%
ROE (%)
Value-9.16
Score0/3
Weight3.53%
1M Return3.06%
Is LGN undervalued or overvalued?
  • LGN scores 1.32/10 on fundamentals and holds a Premium valuation at present. Backed by its -5.25% ROE, -1.73% net margin, -112.49 P/E ratio, 6.22 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.